Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy

Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy

IntroductionStudies have demonstrated that injectable GnRH receptor agonists further suppress cancer progression when paired with radiotherapy (RT) in patients with intermediate- to high-risk prostate adenocarcinoma. Relugolix is a newly available oral GnRH receptor antagonist that achieves swift an...

Descripció completa

Dades bibliogràfiques
Autors principals: Min Jung Koh, Min Ji Koh, Jessica Y. Hsueh, Lindsey Gallagher, Malika Danner, Alan Zwart, Marilyn Ayoob, Deepak Kumar, Michael Carrasquilla, Paul Leger, Nancy A. Dawson, Simeng Suy, Sean P. Collins
Format: Article
Idioma:English
Publicat: Frontiers Media S.A. 2025-01-01
Col·lecció:Frontiers in Oncology
Matèries:
prostate cancer
androgen deprivation therapy
SBRT
health related quality of life
EQ-5D
Accés en línia:https://www.frontiersin.org/articles/10.3389/fonc.2024.1496646/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1496646/full

Ítems similars